| - GRCh37:
- Chr10:43620311-43623717
| RET | | Multiple endocrine neoplasia, type 2 | Uncertain significance (Mar 1, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr10:43606692
- GRCh38:
- Chr10:43111244
| RET | S259N, S288N, S302N, S338N, S391N, S434N, S104N, S180N, S192N | Multiple endocrine neoplasia, type 2 | Uncertain significance (Aug 18, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr10:43604483
- GRCh38:
- Chr10:43109035
| RET | | Multiple endocrine neoplasia, type 2 | Likely benign (Jan 6, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr10:43604470
- GRCh38:
- Chr10:43109022
| RET | | Multiple endocrine neoplasia, type 2 | Likely benign (Oct 24, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr10:43610191
- GRCh38:
- Chr10:43114743
| RET | | Multiple endocrine neoplasia, type 2 | Likely benign (Jan 18, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr10:43597935
- GRCh38:
- Chr10:43102487
| RET | K118N, K161N | Multiple endocrine neoplasia, type 2 | Uncertain significance (Aug 23, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr10:43623684
- GRCh38:
- Chr10:43128236
| RET | | Multiple endocrine neoplasia, type 2 | Likely benign (Feb 27, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr10:43597827
- GRCh38:
- Chr10:43102379
| RET | | Multiple endocrine neoplasia, type 2 | Likely benign (Sep 17, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr10:43622013
- GRCh38:
- Chr10:43126565
| RET | | Multiple endocrine neoplasia, type 2 | Likely benign (Jun 29, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr10:43601809
- GRCh38:
- Chr10:43106361
| RET | | Multiple endocrine neoplasia, type 2 | Likely benign (Apr 21, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr10:43623697
- GRCh38:
- Chr10:43128249
| RET | M1013V, M1064V, M1089V, M963V, M1109V, M626V, M714V, M810V, M847V, M1066V, M606V, M767V, M867V, M977V | Multiple endocrine neoplasia, type 2 | Uncertain significance (Aug 8, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr10:43601804
- GRCh38:
- Chr10:43106356
| RET | | Multiple endocrine neoplasia, type 2 | Likely benign (Jul 22, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr10:43600382
- GRCh38:
- Chr10:43104934
| RET | | Multiple endocrine neoplasia, type 2 | Likely benign (Dec 22, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr10:43600497
- GRCh38:
- Chr10:43105049
| RET | | Multiple endocrine neoplasia, type 2 | Likely benign (Jul 6, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr10:43607650
- GRCh38:
- Chr10:43112202
| RET | | Multiple endocrine neoplasia, type 2 | Likely benign (Mar 12, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr10:43604630
- GRCh38:
- Chr10:43109182
| RET | | Multiple endocrine neoplasia, type 2 | Likely benign (May 21, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr10:43608385
- GRCh38:
- Chr10:43112937
| RET | I236T, I336T, I432T, I482T, I535T, I578T, I183T, I279T, I324T, I95T, I248T, I403T, I446T | Multiple endocrine neoplasia, type 2 | Uncertain significance (Feb 28, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr10:43600381-43600382
- GRCh38:
- Chr10:43104933-43104934
| RET | | Multiple endocrine neoplasia, type 2 | Likely benign (Sep 20, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr10:43609004-43609005
- GRCh38:
- Chr10:43113556-43113557
| RET | R104Q, R288Q, R192Q, R245Q, R257Q, R412Q, R441Q, R455Q, R587Q, R333Q, R345Q, R491Q, R544Q | Multiple endocrine neoplasia, type 2 | Uncertain significance (Sep 21, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr10:43597938
- GRCh38:
- Chr10:43102490
| RET | | Multiple endocrine neoplasia, type 2 | Likely benign (Dec 14, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr10:43614959
- GRCh38:
- Chr10:43119511
| RET | | Multiple endocrine neoplasia, type 2 | Benign (Jan 27, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr10:43610013
- GRCh38:
- Chr10:43114565
| RET | F260L, F413L, F480L, F559L, F509L, F523L, F316L, F612L, F172L, F220L, F313L, F325L, F356L, F401L, F655L | Multiple endocrine neoplasia, type 2 | Uncertain significance (Dec 18, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr10:43620325
- GRCh38:
- Chr10:43124877
| RET | | Multiple endocrine neoplasia, type 2 | Likely benign (Jan 2, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr10:43622099
- GRCh38:
- Chr10:43126651
| RET | P695R, P556R, P709R, P785R, P943R, P951R, P996R, P1039R, P700R, P740R, P797R, P864R, P893R, P907R, P604R, P644R, P697R, P994R | Multiple endocrine neoplasia, type 2 | Uncertain significance (Oct 3, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr10:43604557
- GRCh38:
- Chr10:43109109
| RET | F127C, F139C, F381C, F338C, F235C, F285C, F51C | Multiple endocrine neoplasia, type 2 | Uncertain significance (Sep 15, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr10:43600661
- GRCh38:
- Chr10:43105213
| RET | | Multiple endocrine neoplasia, type 2 | Likely benign (Jun 13, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr10:43607541
- GRCh38:
- Chr10:43112093
| RET | | Multiple endocrine neoplasia, type 2 | Likely benign (Mar 19, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr10:43604491
- GRCh38:
- Chr10:43109043
| RET | N105S, N29S, N359S, N117S, N263S, N316S, N213S | Multiple endocrine neoplasia, type 2 | Uncertain significance (Jun 30, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr10:43619183
- GRCh38:
- Chr10:43123735
| RET | P521S, P617S, P824S, P956S, P473S, P612S, P626S, P657S, P781S, P868S, P911S, P561S, P614S, P702S, P714S, P810S, P860S, P913S | Multiple endocrine neoplasia, type 2 | Uncertain significance (Jun 4, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr10:43601866
- GRCh38:
- Chr10:43106418
| RET | V261I, V208I, V304I, V50I | Multiple endocrine neoplasia, type 2 | Uncertain significance (Aug 26, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr10:43615515
- GRCh38:
- Chr10:43120067
| RET | | Multiple endocrine neoplasia, type 2 | Likely benign (Aug 16, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr10:43596176
- GRCh38:
- Chr10:43100728
| RET | | Multiple endocrine neoplasia, type 2 | Uncertain significance (Apr 22, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr10:43606676
- GRCh38:
- Chr10:43111228
| RET | N254D, N333D, N187D, N297D, N175D, N386D, N99D, N283D, N429D | Multiple endocrine neoplasia, type 2 | Uncertain significance (Apr 24, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr10:43623544
- GRCh38:
- Chr10:43128096
| RET | | Multiple endocrine neoplasia, type 2 | Likely benign (Oct 30, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr10:43598068
- GRCh38:
- Chr10:43102620
| RET | L206F, L163F | Multiple endocrine neoplasia, type 2 | Uncertain significance (Sep 18, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr10:43609078
- GRCh38:
- Chr10:43113630
| RET | F313L, F437L, F569L, F282L, F358L, F129L, F466L, F612L, F217L, F270L, F370L, F480L, F516L | Multiple endocrine neoplasia, type 2 | Uncertain significance (Sep 1, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr10:43610046
- GRCh38:
- Chr10:43114598
| RET | | Multiple endocrine neoplasia, type 2 | Likely benign (Sep 24, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr10:43610201
- GRCh38:
- Chr10:43114753
| RET | | Multiple endocrine neoplasia, type 2 | Likely benign (Sep 26, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr10:43615119
- GRCh38:
- Chr10:43119671
| RET | A501S, A603S, A699S, A713S, A749S, A845S, A362S, A515S, A670S, A757S, A450S, A503S, A591S, A800S, A802S, A410S, A506S, A546S | Multiple endocrine neoplasia, type 2 | Uncertain significance (Sep 20, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr10:43610198
- GRCh38:
- Chr10:43114750
| RET | | Multiple endocrine neoplasia, type 2 | Likely benign (May 12, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr10:43597786
- GRCh38:
- Chr10:43102338
| RET | | Multiple endocrine neoplasia, type 2 | Likely benign (Aug 24, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr10:43604544
- GRCh38:
- Chr10:43109096
| RET | N281D, N135D, N231D, N123D, N334D, N377D, N47D | Multiple endocrine neoplasia, type 2 | Uncertain significance (Aug 6, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr10:43604480
- GRCh38:
- Chr10:43109032
| RET | R101S, R259S, R355S, R113S, R312S | Multiple endocrine neoplasia, type 2 | Uncertain significance (Feb 22, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr10:43601807
- GRCh38:
- Chr10:43106359
| RET | | Multiple endocrine neoplasia, type 2 | Likely benign (Apr 29, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr10:43622186
- GRCh38:
- Chr10:43126738
| RET | A922V, A972V, A1025V, A729V, A814V, A893V, A1068V, A585V, A633V, A673V, A769V, A980V, A1023V, A724V, A726V, A738V, A826V, A936V | Multiple endocrine neoplasia, type 2 | Likely benign (Aug 2, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr10:43609105
- GRCh38:
- Chr10:43113657
| RET | E291K, E367K, E379K, E446K, E525K, E578K, E322K, E138K, E226K, E279K, E475K, E489K, E621K | Multiple endocrine neoplasia, type 2 | Uncertain significance (Feb 19, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr10:43609911
- GRCh38:
- Chr10:43114463
| RET | | Multiple endocrine neoplasia, type 2 | Likely benign (Sep 25, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr10:43617483
- GRCh38:
- Chr10:43122035
| RET | | Multiple endocrine neoplasia, type 2 | Likely benign (Sep 16, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr10:43595986
- GRCh38:
- Chr10:43100538
| RET | | Multiple endocrine neoplasia, type 2 | Likely benign (Oct 12, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr10:43598007
- GRCh38:
- Chr10:43102559
| RET | F185L, F142L | Multiple endocrine neoplasia, type 2 | Uncertain significance (Jun 1, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr10:43607656
- GRCh38:
- Chr10:43112208
| RET | | Multiple endocrine neoplasia, type 2 | Likely benign (Aug 31, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr10:43606754
- GRCh38:
- Chr10:43111306
| RET | V323F, V412F, V125F, V201F, V213F, V359F, V455F, V280F, V309F | Multiple endocrine neoplasia, type 2 | Uncertain significance (Apr 11, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr10:43622101
- GRCh38:
- Chr10:43126653
| RET | | Multiple endocrine neoplasia, type 2 | Likely benign (Dec 24, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr10:43604497
- GRCh38:
- Chr10:43109049
| RET | N318I, N107I, N119I, N215I, N361I, N265I, N31I | Multiple endocrine neoplasia, type 2 | Uncertain significance (Apr 1, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr10:43596112
- GRCh38:
- Chr10:43100664
| RET | | Multiple endocrine neoplasia, type 2 | Likely benign (Aug 19, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr10:43597777
- GRCh38:
- Chr10:43102329
| RET | | Multiple endocrine neoplasia, type 2 | Likely benign (Jan 10, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr10:43608985
- GRCh38:
- Chr10:43113537
| RET | | Multiple endocrine neoplasia, type 2 | Likely benign (Oct 12, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr10:43606844
- GRCh38:
- Chr10:43111396
| RET | V155L, V310L, V339L, V231L, V389L, V442L, V485L, V353L, V243L | Multiple endocrine neoplasia, type 2 | Uncertain significance (Sep 3, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr10:43615120
- GRCh38:
- Chr10:43119672
| RET | A362V, A591V, A749V, A800V, A501V, A503V, A699V, A757V, A802V, A515V, A546V, A603V, A410V, A450V, A506V, A670V, A713V, A845V | Multiple endocrine neoplasia, type 2 | Uncertain significance (Oct 9, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr10:43597998
- GRCh38:
- Chr10:43102550
| RET | | Multiple endocrine neoplasia, type 2 | Likely benign (Jul 5, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr10:43622020
- GRCh38:
- Chr10:43126572
| RET | | Multiple endocrine neoplasia, type 2 | Uncertain significance (Oct 27, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr10:43597937
- GRCh38:
- Chr10:43102489
| RET | P162R, P119R | Multiple endocrine neoplasia, type 2 | Uncertain significance (Sep 27, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr10:43609076-43609077
- GRCh38:
- Chr10:43113628-43113629
| RET | C611Y, C357Y, C216Y, C281Y, C515Y, C128Y, C269Y, C479Y, C568Y, C312Y, C369Y, C436Y, C465Y | Multiple endocrine neoplasia, type 2 | Pathogenic (Apr 12, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr10:43604493
- GRCh38:
- Chr10:43109045
| RET | R106W, R30W, R118W, R264W, R360W, R214W, R317W | Multiple endocrine neoplasia, type 2 | Uncertain significance (Sep 2, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr10:43597812
- GRCh38:
- Chr10:43102364
| RET | | Multiple endocrine neoplasia, type 2 | Likely benign (Oct 13, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr10:43606882
- GRCh38:
- Chr10:43111434
| RET | Q351H, Q243H, Q322H, Q365H, Q255H, Q401H, Q167H, Q454H, Q497H | Multiple endocrine neoplasia, type 2 | Uncertain significance (May 9, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr10:43601871
- GRCh38:
- Chr10:43106423
| RET | | Multiple endocrine neoplasia, type 2 | Likely benign (May 7, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr10:43614987
- GRCh38:
- Chr10:43119539
| RET | L462F, L626F, L756F, L406F, L471F, L547F, L559F, L669F, L366F, L713F, L801F, L318F, L457F, L459F, L502F, L655F, L705F, L758F | Multiple endocrine neoplasia, type 2 | Uncertain significance (May 7, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr10:43607646
- GRCh38:
- Chr10:43112198
| RET | C498Y, C211Y, C242Y, C395Y, C409Y, C199Y, C287Y, C445Y, C58Y, C146Y, C299Y, C366Y, C541Y | Multiple endocrine neoplasia, type 2 | Likely pathogenic (May 20, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr10:43597847
- GRCh38:
- Chr10:43102399
| RET | L132R | Multiple endocrine neoplasia, type 2 | Uncertain significance (May 4, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr10:43619104
- GRCh38:
- Chr10:43123656
| RET | | Multiple endocrine neoplasia, type 2 | Likely benign (Jun 3, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr10:43606854
- GRCh38:
- Chr10:43111406
| RET | T392N, T488N, T234N, T313N, T342N, T445N, T158N, T246N, T356N | Multiple endocrine neoplasia, type 2 | Uncertain significance (Dec 2, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr10:43620322
- GRCh38:
- Chr10:43124874
| RET | | Multiple endocrine neoplasia, type 2 | Likely benign (May 3, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr10:43601846
- GRCh38:
- Chr10:43106398
| RET | R254P, R297P, R201P, R43P | Multiple endocrine neoplasia, type 2 | Uncertain significance (May 22, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr10:43604562
- GRCh38:
- Chr10:43109114
| RET | G53S, G237S, G287S, G340S, G129S, G141S, G383S | Multiple endocrine neoplasia, type 2 | Uncertain significance (Apr 28, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr10:43604531
- GRCh38:
- Chr10:43109083
| RET | | Multiple endocrine neoplasia, type 2 | Likely benign (Apr 28, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr10:43601970
- GRCh38:
- Chr10:43106522
| RET | | Multiple endocrine neoplasia, type 2 | Likely benign (Apr 28, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr10:43596111
- GRCh38:
- Chr10:43100663
| RET | G93D | Multiple endocrine neoplasia, type 2 | Uncertain significance (Apr 28, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr10:43600567
- GRCh38:
- Chr10:43105119
| RET | E222K, E265K, E11K, E169K | Multiple endocrine neoplasia, type 2 | Uncertain significance (Apr 20, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr10:43601845
- GRCh38:
- Chr10:43106397
| RET | R254S, R297S, R201S, R43S | Multiple endocrine neoplasia, type 2 | Uncertain significance (Apr 18, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr10:43596085
- GRCh38:
- Chr10:43100637
| RET | | Multiple endocrine neoplasia, type 2 | Likely benign (Apr 11, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr10:43620421
- GRCh38:
- Chr10:43124973
| RET | | Multiple endocrine neoplasia, type 2 | Likely benign (Apr 11, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr10:43601997-43601998
- GRCh38:
- Chr10:43106549-43106550
| RET | V351fs, V97fs | Multiple endocrine neoplasia, type 2 | Pathogenic (Jun 9, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr10:43609941
- GRCh38:
- Chr10:43114493
| RET | D289E, D377E, D535E, D148E, D292E, D456E, D631E, D236E, D301E, D485E, D499E, D196E, D332E, D389E, D588E | Multiple endocrine neoplasia, type 2 | Uncertain significance (May 9, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr10:43601930
- GRCh38:
- Chr10:43106482
| RET | A71V, A325V, A229V, A282V | Multiple endocrine neoplasia, type 2 | Uncertain significance (Apr 10, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr10:43609973-43609975
- GRCh38:
- Chr10:43114525-43114527
| RET | L208del, L389del, L600del, L160del, L468del, L248del, L301del, L304del, L344del, L401del, L547del, L313del, L497del, L511del, L643del | Multiple endocrine neoplasia, type 2 | Uncertain significance (Apr 6, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr10:43615667
- GRCh38:
- Chr10:43120219
| RET | | Multiple endocrine neoplasia, type 2 | Uncertain significance (Apr 22, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr10:43613854
- GRCh38:
- Chr10:43118406
| RET | L434R, L677R, L685R, L290R, L338R, L378R, L429R, L730R, L773R, L443R, L474R, L627R, L641R, L728R, L431R, L519R, L531R, L598R | Multiple endocrine neoplasia, type 2 | Uncertain significance (Mar 31, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr10:43619189
- GRCh38:
- Chr10:43123741
| RET | E619Q, E628Q, E704Q, E870Q, E913Q, E523Q, E812Q, E862Q, E958Q, E475Q, E563Q, E616Q, E716Q, E783Q, E826Q, E614Q, E659Q, E915Q | Multiple endocrine neoplasia, type 2 | Uncertain significance (Mar 29, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr10:43606872
- GRCh38:
- Chr10:43111424
| RET | R252K, R348K, R319K, R451K, R494K, R164K, R240K, R362K, R398K | Multiple endocrine neoplasia, type 2 | Uncertain significance (Jun 9, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr10:43600649
- GRCh38:
- Chr10:43105201
| RET | | Multiple endocrine neoplasia, type 2 | Likely benign (Mar 26, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr10:43601983
- GRCh38:
- Chr10:43106535
| RET | N300H, N89H, N247H, N343H | Multiple endocrine neoplasia, type 2 | Uncertain significance (Mar 19, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr10:43597976
- GRCh38:
- Chr10:43102528
| RET | R132L, R175L | Multiple endocrine neoplasia, type 2 | Uncertain significance (Mar 18, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr10:43609980
- GRCh38:
- Chr10:43114532
| RET | | Multiple endocrine neoplasia, type 2 | Likely benign (Mar 14, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr10:43610178
- GRCh38:
- Chr10:43114730
| RET | | Multiple endocrine neoplasia, type 2 | Likely benign (Mar 14, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr10:43617387
- GRCh38:
- Chr10:43121939
| RET | | Multiple endocrine neoplasia, type 2 | Likely benign (May 4, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr10:43620380
- GRCh38:
- Chr10:43124932
| RET | V562L, V698L, V997L, V514L, V655L, V667L, V743L, V851L, V909L, V653L, V755L, V901L, V602L, V658L, V822L, V865L, V952L, V954L | Multiple endocrine neoplasia, type 2 | Uncertain significance (Jun 19, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr10:43622031
- GRCh38:
- Chr10:43126583
| RET | L686F, L717F, L762F, L774F, L920F, L581F, L672F, L677F, L971F, L533F, L870F, L928F, L1016F, L621F, L674F, L841F, L884F, L973F | Multiple endocrine neoplasia, type 2 | Uncertain significance (Mar 16, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr10:43572762
- GRCh38:
- Chr10:43077314
| RET | L19P | Hereditary cancer-predisposing syndrome, Multiple endocrine neoplasia, type 2 | Uncertain significance (Dec 18, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr10:43615105
- GRCh38:
- Chr10:43119657
| RET | H501L, H510L, H708L, H744L, H795L, H498L, H541L, H586L, H797L, H840L, H357L, H405L, H445L, H665L, H694L, H496L, H598L, H752L | Multiple endocrine neoplasia, type 2 | Uncertain significance (Aug 7, 2022) | criteria provided, single submitter |